Working in concert with Alberta Health Services Public Health Officers, leading clinicians and Alberta Public Laboratories, the team will recruit the Alberta Childhood COVID-19 Cohort (ABCCC), consisting of all children under the age of 18 who undergo testing for the SARS-COV2 virus. Specifically, the project will: 1) assess the role of children’s immune response as well as their genetic makeup in order to determine risk factors for severe illness and gain insight into targeted treatments, and 2) study the epidemiology of pediatric COVID-19 infections by reading the viral genome to determine the origin and transmission patterns in Alberta of pediatric COVID-19 infections.
ActiveHealth
Clinical utility of ClarityDX Prostate for widespread public adoption in Canada
Competition/Funding OpportunityGenome Canada – Canadian Biotechnology Innovation and Commercialization Initiative
Project Lead(s)/Co-Lead(s)Colin Coros (Nanostics) and John Lewis (University of Alberta)